Table 1.
Usage of HbV as a transfusion alternative (substitute for RBC transfusion).
Application | Animal Species | Brief Description of Main Results | References |
---|---|---|---|
Isovolemic hemodilution (repeated injection at hemorrhage) | Wistar rats | 90% blood exchange with HbV suspended in HSA showed stable hemodynamics | [22] |
Syrian golden hamsters | 80% blood exchange with HbV suspended in HSA showed stable hemodynamics and microvascular responses | [23,24] | |
Wistar rats | 40% blood exchange with HbV suspended in rHSA, and 14 days observation | [15] | |
Wistar rats | 60% blood exchange with a plasma expander (high Mw HES, low Mw HES, MFG, or rHSA) and subsequent injection of HbV (20 mL/kg) | [21] | |
Hemorrhagic shock | Wistar rats | 50% blood withdrawal and resuscitation, 6 h observation | [25] |
Japanese white rabbits |
Twice of 40% blood withdrawal and resuscitation | [26] | |
New Zealand white rabbits |
Withdrawing blood to a mean arterial blood pressure of 30–35 mm Hg, and resuscitation with HbV/rHSA | [27] | |
Wistar rats | 50% blood withdrawal and resuscitation, 14 days observation | [28] | |
Lewis rats | 40% blood withdrawal and resuscitation, 6 h observation showed absence of acute lung injury. One-year-stored HbV was used for resuscitation | [29] | |
Beagle dogs | 50% blood withdrawal and resuscitation. 4 h observation of hemodynamics | [30] | |
Beagle dogs | 40% blood withdrawal and resuscitation, one year safety observation | [31] | |
Uncontrolled hemorrhage | Wistar rats | Animals were heparinized and bled continuously from caudal artery. Injection of HbV suspended in HSA extended survival | [32] |
Priming of ECMO | Wistar rats | Use of HbV for cardiopulmonary bypass priming prevented neurocognitive decline | [33] |